IRIS Accounts Production v25.3.0.601 15583955 Board of Directors 22.3.24 31.3.25 31.3.25 false true false false true false Ordinary £1 1.00000 Ordinary A £1 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh155839552024-03-21155839552025-03-31155839552024-03-222025-03-31155839552024-03-2115583955ns15:EnglandWales2024-03-222025-03-3115583955ns14:PoundSterling2024-03-222025-03-3115583955ns10:Director12024-03-222025-03-3115583955ns10:PrivateLimitedCompanyLtd2024-03-222025-03-3115583955ns10:SmallEntities2024-03-222025-03-3115583955ns10:AuditExempt-NoAccountantsReport2024-03-222025-03-3115583955ns10:SmallCompaniesRegimeForDirectorsReport2024-03-222025-03-3115583955ns10:SmallCompaniesRegimeForAccounts2024-03-222025-03-3115583955ns10:FullAccounts2024-03-222025-03-3115583955ns10:OrdinaryShareClass12024-03-222025-03-3115583955ns10:OrdinaryShareClass22024-03-222025-03-3115583955ns5:CurrentFinancialInstruments2025-03-3115583955ns5:ShareCapital2025-03-3115583955ns5:RetainedEarningsAccumulatedLosses2025-03-3115583955ns10:RegisteredOffice2024-03-222025-03-3115583955ns5:ComputerEquipment2024-03-222025-03-3115583955ns5:ComputerEquipment2025-03-3115583955ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3115583955ns5:AcceleratedTaxDepreciationDeferredTax2025-03-3115583955ns5:DeferredTaxation2024-03-222025-03-3115583955ns5:DeferredTaxation2025-03-3115583955ns10:OrdinaryShareClass12025-03-3115583955ns10:OrdinaryShareClass22025-03-31
REGISTERED NUMBER: 15583955 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

22 MARCH 2024 TO 31 MARCH 2025

FOR

KENT & SUSSEX ORTHOPAEDICS LTD

KENT & SUSSEX ORTHOPAEDICS LTD (REGISTERED NUMBER: 15583955)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 22 MARCH 2024 TO 31 MARCH 2025










Page

Balance Sheet 1

Notes to the Financial Statements 3


KENT & SUSSEX ORTHOPAEDICS LTD (REGISTERED NUMBER: 15583955)

BALANCE SHEET
31 MARCH 2025

Notes £    £   
FIXED ASSETS
Tangible assets 5 824

CURRENT ASSETS
Debtors 6 14,994
Cash at bank 44,947
59,941
CREDITORS
Amounts falling due within one year 7 31,183
NET CURRENT ASSETS 28,758
TOTAL ASSETS LESS CURRENT
LIABILITIES

29,582

PROVISIONS FOR LIABILITIES 8 206
NET ASSETS 29,376

CAPITAL AND RESERVES
Called up share capital 9 2
Retained earnings 29,374
SHAREHOLDERS' FUNDS 29,376

KENT & SUSSEX ORTHOPAEDICS LTD (REGISTERED NUMBER: 15583955)

BALANCE SHEET - continued
31 MARCH 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 October 2025 and were signed on its behalf by:





C L Buckle - Director


KENT & SUSSEX ORTHOPAEDICS LTD (REGISTERED NUMBER: 15583955)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 22 MARCH 2024 TO 31 MARCH 2025


1. STATUTORY INFORMATION

Kent & Sussex Orthopaedics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 15583955

Registered office: 48 St Leonards Road
Bexhill on Sea
East Sussex
TN40 1JB

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
The turnover shown in the profit and loss account represents amounts receivable for services provided during the year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 25% on cost

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


KENT & SUSSEX ORTHOPAEDICS LTD (REGISTERED NUMBER: 15583955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 22 MARCH 2024 TO 31 MARCH 2025


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

5. TANGIBLE FIXED ASSETS
Equipment
£   
COST
Additions 1,099
At 31 March 2025 1,099
DEPRECIATION
Charge for period 275
At 31 March 2025 275
NET BOOK VALUE
At 31 March 2025 824

KENT & SUSSEX ORTHOPAEDICS LTD (REGISTERED NUMBER: 15583955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 22 MARCH 2024 TO 31 MARCH 2025


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 11,222
Prepayments and accrued income 3,772
14,994

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 2,121
Corporation tax 15,214
PAYE and social security 2,407
Directors' current accounts 10,061
Accruals and deferred income 1,380
31,183

8. PROVISIONS FOR LIABILITIES
£   
Deferred tax
Accelerated capital allowances 206

Deferred
tax
£   
Charge to Profit and Loss Account during period 206
Balance at 31 March 2025 206

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1 1
1 Ordinary A £1 1 1
2

1 Ordinary share of £1 and 1 Ordinary A share of £1 were allotted and were fully paid for cash at par during the period.